Will the return of the 2.3% excise tax change how medtech companies do business?
New virtual and in-person workshops will bring together FDA and industry experts and stakeholders on a variety of key issues.
PwC’s Health Research Institute releases its annual Top Health Issues report.
This year the company exceeded its expectations, too.
The President’s actions (or distractions) may be detrimental to Western medical device companies.
ECRI releases its top 10 list of health technology hazards for 2018.
Recognizing that additive manufacturing is an emerging technology, the agency is providing an outline of its current thinking about the technical aspects of AM processes.
With the increase of diabetes prevalence in Asia and the rise of Asia’s middle classes, the demand for newer and better treatments will provide opportunities for Western medtech companies.
As standalone software becomes increasingly sophisticated, a number of regulatory bodies have begun to draft separate guidelines to ensure quality control, expedite product approval, and improve patient access to new technologies.
Global sports medicine is predicted to grow to around $35 billion by 2022, with the Asian market growing at a compound annual growth rate of nearly 7 percent.